Patient‐related risk factors include advanced age, history of AF, history of HF, renal failure, hypertension, chronic obstructive pulmonary disease, post‐operative withdrawal or absence of beta‐blocker, or angiotensin‐converting enzyme inhibitor (ACE inhibitor) therapy.197, 200. The gene discussed is ACE; the disease is chronic obstructive pulmonary disease.